Colorectal cancer in ulcerative colitis: Survival in patients with and without colorectal cancer symptoms
β Scribed by Dr. Francis M. Giardiello; Ahmet K. Gurbuz; Theodore M. Bayless; Steven N. Goodman; John H. Yardley
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 466 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
β¦ Synopsis
Patients with ulcerative colitis are at increased risk for colorectal adenocarcinoma compared with the general population. Although surveillance for colorectal malignancy and dysplasia (a premalignant lesion) has been recommended, a benefit in reducing mortality from colorectal cancer via surveillance or prophylactic colectomy is still being debated. We reviewed the outcome of 40 consecutive patients with ulcerative colitis with colorectal adenocarcinoma diagnosed between 1956 and 1991
π SIMILAR VOLUMES
Conflicting data exist on the prognosis of hereditary colorectal cancer. HNPCC patients, in particular, are often reported to have a better survival. We examined 2,340 colorectal-cancer patients treated in our Institution: 144 HNPCC patients (Amsterdam Criteria), 161 FAP patients and 2,035 patients
A cohort of 5,546 ulcerative colitis patients was identified from the Danish Hospital Discharge Register for 1977-1989. Patients not included in the cohort comprised those with proctitis, those treated in outpatient clinics and those for whom follow-up was less than I year. The cohort was linked to
on behalf of the Japanese Society for Cancer of the Colon and Rectum Background: The clinicopathological features of ulcerative colitis-associated colorectal cancer (UC-CRC) have not yet been fully clarified, especially in Asian populations. This study aimed to clarify the prognosis and clinicopatho